- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Telomolecular Unveils a New Cosmetic Skin Cream That Utilizes Age-Reversing Science at the Molecular Level
Telomolecular Corp., a local nanotechnology company that develops biopharmaceutical medicines designed to treat aging and age-related disease introduces "bĭm·ə·nē™" the first product designed to truly deliver important beauty ingredients where they are needed - in the dermal layer of your skin.
Collagen is a natural protein that is abundant in young, beautiful skin. Many cosmetic lines claim to fight aging with collagen. However, the collagen protein is too large to make its way into your skin without an effective delivery system.
bĭm·ə·nē™ enlists tiny agents called "nanoparticles," designed to carry collagen directly to the front lines of the aging conflict. bĭm·ə·nē™ delivers Type III Collagen, the same type of collagen that makes a baby's skin so soft and supple. bĭm·ə·nē™'s nanotechnologies are designed to work in harmony with its other cutting-edge ingredients. bĭm·ə·nē™ also contains hyaluranic acid, pentapeptides and a penetrating form of Vitamin C which enhances its ability to support, protect and renew living skin.
According to Senior Vice President, David Dollar, "This is a revolutionary face cream - a product so different and innovative, we believe it could generate enormous consumer interest."
Telomolecular Corp. started selling bĭm·ə·nē™ in December of 2007 and in the following months anticipates the release of another innovative skin cream that can be used in conjunction with bĭm·ə·nē™. The cosmetic, called "NanoSOD" contains powerful antioxidants delivered to the skin cells via nanoparticles. NanoSOD is designed to protect skin cells from the everyday environmental damage that ages the skin.
bĭm·ə·nē™ retails for $149.95 for a 1.5 ounce jar. To order, log on to www.bimene.com or call (916) 851-0271.
About Telomolecular Corp.
Telomolecular Corp is a pioneer in tissue regeneration, anti-aging and cancer therapies. Telomolecular’s scientists were brought together from important U.S. universities and are leaders in the development of nanotechnologies for cosmetic and pharmaceutical applications. Log on to www.telomolecular.com for more information.
Media partners are invited to attend the product launch celebration at Telomolecular California headquarters March 7, 2008, 6:30 pm – 8:30 pm, Telomolecular, 10933 Trade Center Drive #100, Rancho Cordova, CA 95670. Media passes are limited. RSVP to Denny Jones 916-379-5877 or .
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. When used in this press release, the words "expects," "anticipates," "believes," "plans," "will" and similar expressions are intended to identify forward-looking statements. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, including product releases and marketing efforts, are forward-looking statements that involve risks and uncertainties. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. Some of these risks include, but are not limited to, adequacy of cash and our need for future financing, the demand for our products and our dependence on key personnel. These forward-looking statements speak only as of the date hereof. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in prior disclosures to investors. The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.
For more information, please click here
David Dollar, Senior Vice President, 916-851-0271
Angela A. Hughes, 916-397-4585
Copyright © Business Wire 2008If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Dais Analytic Unveils New Version of Aqualyte Membrane Technology: Updates to the Basis of the Company's Industry-Changing Nanotechnology Designed to Strengthen Position in Global Air, Energy, and Water Markets June 26th, 2015
Application of Egg White in Production of Nanoparticles April 6th, 2015
Sunblock poses potential hazard to sea life August 20th, 2014
Indefinite Life Extension Activists Organize Online Demonstration February 26th, 2015
Conceptual Nanomedical Lipofuscin Removal Strategy April 29th, 2013
utsandiego.com November 22nd, 2012